🇺🇸 FDA
Patent

US 9169280

Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof

granted A61PA61P25/28

Quick answer

US patent 9169280 (Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof) held by Phenomenome Discoveries Inc. expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phenomenome Discoveries Inc.
Grant date
Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61P, A61P25/28